Navigation Links
Women altering menstruation cycles in large numbers, UO study shows
Date:5/9/2013

EUGENE, Ore. -- A surprisingly large number of women 18 or older choose to delay or skip monthly menstruation by deviating from the instructions of birth-control pills and other hormonal contraceptives, a team of University of Oregon researchers and others found in a study of female students at the university.

Most women who alter bleeding cycles do so for convenience rather than to avoid menstrual symptoms, and many learn about the option from nonmedical sources, according to research by the university's Department of Human Physiology, Portland-based Oregon Health and Sciences University and Eastern Michigan University. The study is published in Contraception, the official journal of the Association of Reproductive Health Professionals and the Society of Family Planning.

"These findings emphasize the need for health care providers to carefully interview combined hormonal contraceptive users on how they are using their method for example, many women may be skipping pills to extend their cycles," said researcher Christopher Minson, a human physiology professor at the University of Oregon. "With a greater understanding of the issues, health care providers may be able to more effectively engage in conversations with college-aged women and educate them about available options."

As research indicates that reducing the occurrence of menstruation is safe and can even be beneficial, women are increasingly using hormonal contraceptives to alter bleeding cycles. But there has been a lack of information concerning why women do so and from whom they receive information regarding this option.

In a survey of undergraduate and graduate students, 17 percent reported altering their scheduled bleeding pattern by deviating from the instructions of hormonal contraceptives, which include birth-control pills, vaginal contraceptive rings and transdermal contraceptive patches.

Half of these women reported that they did so for conven
'/>"/>

Contact: Matt Cooper
mattc@uoregon.edu
541-346-8875
University of Oregon
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Brain anatomy of dyslexia is not the same in men and women, boys and girls
2. Elseviers Maturitas publishes clinical guide on endometrial assessment in postmenopausal women
3. Shared Medical Resources, LLC files suit against Histologics, LLC, Womens Health Laboratories and Avero Diagnostics for Willful Patent Infringement
4. Pregnant women with high celiac disease antibodies are at risk for low birth weight babies
5. Women with HIV shown to have elevated resting energy expenditure
6. Inter-American Network of Science Academies celebrates women scientists -- April 17 event
7. Study reveals risk factors for blood clots in pregnant and postnatal women
8. Men and women get sick in different ways
9. European Guidance for the diagnosis & management of osteoporosis in postmenopausal women
10. Stereotyping prime obstacle to women in commercial science
11. New book celebrates women scientists in the Americas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015   Codonics ... safety systems and image documentation solutions and ... comprehensive, technologically-advanced automation solutions, is pleased to ... The Codonics® Safe Label System® (SLS), an ... conjunction with the Omnicell Anesthesia Workstation, helps ...
(Date:5/21/2015)... According to a new ... Software, Services), by Applications (Surveillance (Airborne, Maritime, Land), ... (Military & Defense & Commercial) - Global Forecast ... is expected to grow from $7252.0 Million in ... Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/19/2015)... -- Technology is rapidly advancing, outpacing enterprises, ability to secure ... and their management are soon to be rendered obsolete ... as those developed by the FIDO Alliance™. With the ... BYOD, COPE, IoT, and mobile payments, the interconnected online ... In response to the call for seamless, secure, ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... mechanism has been discovered in a microorganism that thrives in ... key processes in human cells, and in a better understanding ... study is published today in the online version the American ... group at the Department of Molecular Evolution at Uppsala University ...
... innate defence system against deadly bacteria. However, how the step ... not yet known. To date, B. Pseudomallei, a ... can remain hidden in the human body for many years ... suddenly become activated and spread throughout the body, resulting in ...
... Measures to tackle the human impact on biodiversity ... countries working with common goals and frameworks. This ... European Science Foundation (ESF), which moved towards establishing ... and biodiversity analysis on the back of existing ...
Cached Biology News:New cell division mechanism discovered 2European biodiversity and ecosystem scientists merge and gear up for long-term research 2
(Date:6/1/2015)...   Epic Sciences, Inc. , a private diagnostics ... personalize and advance the treatment and management of cancer, ... under its existing credit facility with Silicon Valley ... capacity of the facility from $5 million to $15 ... to April 1, 2019.  The availability of additional capital ...
(Date:6/1/2015)... , May 29, 2015 ... the addition of the "2015 Strategies ... report to their offering. ... and provides a comprehensive analysis of the ... size, growth, regulatory requirements, technological trends, competitive ...
(Date:6/1/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") collaboration partner, presented ... trial of HMP,s c-Met inhibitor savolitinib (AZD6094) combined ... lung cancer ("NSCLC"). AZD9291 is AstraZeneca,s ... (EGFR). Preliminary data on the activity of AZD9291 ...
(Date:5/31/2015)... (PRWEB) May 31, 2015 Grow Med ... that enables growers to progress at their own pace ... white papers, efficacy reports, and both scientific and other ... help them produce their best harvest yet! , ... marijuana is the fastest-growing industry in the U.S. and ...
Breaking Biology Technology:Epic Sciences Expands Silicon Valley Bank Credit Facility 2Epic Sciences Expands Silicon Valley Bank Credit Facility 3Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3Grow Med University: a Brand New Online Hydroponics Course 2
... Superiority Over,Market-Leading Stent in Clinical Trials, Now Available in United ... Treatment ... Abbott today,announced that the U.S. Food and Drug Administration ... the treatment of,coronary artery disease. XIENCE V is the only ...
... new products coming soon to Bioniche,s growing line of injectable ... ... Bioniche Pharma, a leading,developer and manufacturer of injectable pharmaceuticals, announced today,the ... (edrophonium chloride injection, USP) 10 mg/mL, 15 mL vial -- ENLON-PLUS(R) ...
... and Sales; Susan Koppy ... Corporate Development, PT. RICHMOND, Calif., July 2 Transcept ... position of,Vice President, Marketing and Sales and Susan Koppy to ... Ms. Koppy will report,to President & Chief Executive Officer Glenn ...
Cached Biology Technology:FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4
... FAST RED Chromogen System consists ... substrate buffer. FAST RED reacts ... phosphatase to produce red staining ... The FAST RED ...
Mouse Cell Line Slides...
Human Cell Line Slides...
... most comprehensive, cost-effective solution to your ... unprecedented quality into both our products ... detection chemistries and antibodies that have ... It also includes our competitively priced ...
Biology Products: